Salt Lake City, UT, Nov. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --NutraNomics, Inc. (NNRX) announced today a strategic partnership with Tempus Bio Technologies focused on providing new and improved products to the supplement market.
Tempus Bio Technologies brings cutting-edge expertise to the challenge of improving supplement formulations and delivery systems. They are experts in bio and nano technology and, as a company, are endeavoring to change the face of supplementation by integrating technological advances with time-proven ingredients.
“We live at the interface between medicine and supplementation and we use the best of both worlds to enhance the health and well-being of everyone,” says Dr. Templeman, President of Tempus Bio Technologies.
"NutraNomics is excited and committed to the highest levels of innovation. Tempus Bio Technologies provides a unique perspective to this exciting partnership both from the physician community and the science community. This partnership expands us into smart, strategic alignments that are anticipating our services in not only CBD but also other plant based ingredients, textiles, materials, ointments and creams. We look forward to providing new and enhanced products that will be on the market in 2019,” states NutraNomics CEO and President, Jonathan Bishop.
Safe Harbor Statement
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results or implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.